$0.0685 (-25.62%)

Volume: 41.077M

Closed: Jan 27, 2023

Hollow Logo Score: -5.584
ContraFect Corporation Stock
$0.0685 (-25.62%)

Volume: 41.077M

Closed: Jan 27, 2023

Score Hollow Logo -5.584
NASDAQ:CFRX

ContraFect Corporation Stock Statistics

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior. Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average. Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Dates Signal Change
2023-01-25 - 2023-01-27 SELL -31.57
2023-01-24 - 2023-01-25 HOLD -15.81
2023-01-12 - 2023-01-24 SELL 20.10
2023-01-10 - 2023-01-12 HOLD -5.71
2022-12-01 - 2023-01-10 SELL -33.38

Stock Score Effectiveness

Bollinger Stock Signal Effectiveness

Macd Signal Effectiveness

Mv7 Signal Effectiveness

Score signal

Bollinger Signal Statistics

MV signal statistics

MACD Signal Statistics

Hot Stocks To Watch:

About ContraFect Corporation

ContraFect ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus aureus bacteremia. The company also develops CF-296, an engineered lysin, used for treatment of the in... CFRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT